Immunopharmacology and Immunotoxicology
Published by Taylor & Francis
ISSN : 0892-3973 eISSN : 1532-2513
Abbreviation : Immunopharmacol. Immunotoxicol.
Aims & Scope
The journal Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system.
Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs.
Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal.
The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc.
The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest.
Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome.
With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more.
Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 3 |
2024 | 2.90 |
Journal Rank
Year | Value |
---|---|
2024 | 7752 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 923 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.725 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 63 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Experimental animal models for rheumatoid arthritis
Citation: 225
Authors: Narayan, Lokesh K., Kedar S.
-
IMMUNOSTIMULATING EFFECTS OF ACIDIC POLYSACCHARIDES EXTRACT OF<i>PANAX GINSENG</i>ON MACROPHAGE FUNCTION
Citation: 153
Authors: Jae-Yong, Ji-Young, Yeon-Sook, Hyun-Ok, Dong-Kwon, Suhkneung
-
TGF-β: the connecting link between nephropathy and fibrosis
Citation: 151
Authors: Brijesh, Dimple, Madhusudan N.
-
Chloroquine cardiomyopathy – a review of the literature
Citation: 147
Authors: Ernst, Reinhard, Thorsten
-
Phytoncides (Wood Essential Oils) Induce Human Natural Killer Cell Activity
Citation: 143
Authors: Qing, Ari, Hiroki, Yoshifumi, Alan M., Tomoyuki, Kanehisa
-
Anti-inflammatory and immunomodulatory effects of<i>Spirulina platensis</i>in comparison to<i>Dunaliella salina</i>in acetic acid-induced rat experimental colitis
Citation: 137
Authors: Mohamed M., Sameh M., Fedekar F., Samar S.